首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Double-blind comparative study of two dosage regimens of cefaclor and amoxicillin-clavulanic acid in the outpatient treatment of soft tissue infections.
【2h】

Double-blind comparative study of two dosage regimens of cefaclor and amoxicillin-clavulanic acid in the outpatient treatment of soft tissue infections.

机译:头孢克洛和阿莫西林-克拉维酸两种门诊软组织感染门诊治疗的双盲比较研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

A total of 88 patients were enrolled in a double-blind comparison of cefaclor and amoxicillin-clavulanic acid for the outpatient treatment of soft tissue infections (abscesses, cellulitis, and impetigo). In 84 clinically evaluable patients, high cure rates were obtained for all treatment groups (64 to 85%). Patients who received amoxicillin-clavulanic acid had a much higher incidence of gastrointestinal side effects than did patients who received cefaclor (34 versus 3%, P less than 0.005). However, only five patients with gastrointestinal reactions to amoxicillin-clavulanic acid had symptoms severe enough to warrant halting the completion of antibiotic therapy.
机译:共有88位患者接受了头孢克洛和阿莫西林-克拉维酸在软组织感染(脓肿,蜂窝织炎和脓疱病)的门诊治疗中的双盲比较。在84位临床上可评估的患者中,所有治疗组的治愈率均很高(64%至85%)。接受阿莫西林-克拉维酸治疗的患者胃肠道副作用的发生率比接受头孢克洛的患者高得多(34比3%,P小于0.005)。但是,只有五名对阿莫西林-克拉维酸有胃肠道反应的患者的症状严重到足以终止抗生素治疗的时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号